Publications - 'R'

Publications 476 - 500 de 1476
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
REDUCED INTENSITY ALLOGENEIC SCT ACHIEVES LONG TERM DISEASE CONTROL IN PATIENTS WITH FOLLICULAR LYMPHOMA RELAPSING AFTER A PRIOR AUTOLOGOUS SCT AND MAY OVERCOME THE ADVERSE IMPACT OF EARLY RELAPSE POST AUTOSCT. AN EBMT LYMPHOMA WORKING PARTY ANALYSIS
P. Robinson; A. Boumendil; H. Finel; H. Schouten; J. Maertens; A. Sureda; A. Rambaldi; A. Wahlin; D. Blaise; E. Deconinck; C. Cordonnier; I. Yakoub-Agha; L. Volin; A. Vitek; N. Russell; A. Ganser; J. Veelken; E. Vandenberghe; E. Faber; S. Montoto; P. Dreger; EBMT
2014
REDUCED INTENSITY ALLOGENEIC SCT ACHIEVES LONG TERM DISEASE CONTROL IN PATIENTS WITH FOLLICULAR LYMPHOMA RELAPSING AFTER A PRIOR AUTOLOGOUS SCT AND MAY OVERCOME THE ADVERSE IMPACT OF EARLY RELAPSE POST AUTOSCT. AN EBMT LYMPHOMA WORKING PARTY ANALYSIS
P. Robinson; A. Boumendil; H. Finel; H. Schouten; J. Maertens; A. Sureda; A. Rambaldi; A. Wahlin; D. Blaise; E. Deconinck; C. Cordonnier; I. Yakoub-Agha; L. Volin; A. Vitek; N. Russell; A. Ganser; J. Veelken; E. Vandenberghe; E. Faber; S. Montoto; P. Dreger; EBMT
2014
Reduced microbial diversity induces larger volatile organic compound emissions from soils
L. Abis; B. Loubet; R. Ciuraru; F. Lafouge; S. Houot; V. Nowak; J. Tripied; S. Dequiedt; P.Alain Maron; S. Sadet-Bourgeteau
2020
10.1038/s41598-020-63091-8
Reduced order controller design for Timoshenko beam: A port Hamiltonian approach
Y. Wu; B. Hamroun; Y. Le Gorrec; B. Maschke
2017
10.1016/j.ifacol.2017.08.547
Reduced Order LQG Control Design for Infinite Dimensional Port Hamiltonian Systems
Y. Wu; B. Hamroun; Y. Le Gorrec; B. Maschke
2021
10.1109/TAC.2020.2997373
Reduced order LQG control design for port Hamiltonian systems
Y. Wu; B. Hamroun; Y. Le Gorrec; B. Maschke
2018
10.1016/j.automatica.2018.05.003
Reduced order optimal control of infinite dimensional port Hamiltonian systems
Y. Wu; B. Hamroun; Y. Le Gorrec; B. Maschke
2019
Reduced order optimal control of infinite dimensional port Hamiltonian systems
Y. Wu; B. Hamroun; Y. Le Gorrec; B. Maschke
2019
Reduced reference 3D mesh quality assessment based on statistical models
I. Abouelaziz; M. Omari; M.El Hassouni; H. Cherifi
2015
10.1109/SITIS.2015.129
Reduced reference image quality assessment based on statistics in empirical mode decomposition domain
A.Ait Abdelouahad; M.El Hassouni; H. Cherifi; D. Aboutajdine
2014
10.1007/s11760-012-0407-0
Reduced reference mesh visual quality assessment based on convolutional neural network
I. Abouelaziz; A. Chetouani; M.El Hassouni; H. Cherifi
2018
10.1109/SITIS.2018.00099
Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease
E. Cavedo; B. Dubois; O. Colliot; S. Lista; B. Croisile; G.Louis Tisserand; J. Touchon; A. Bonafe; P.J. Ousset; O. Rouaud; F. Ricolfi; A. Vighetto; F. Pasquier; S. Galluzzi; C. Delmaire; M. Ceccaldi; N. Girard; S. Lehericy; F. Duveau; M. Chupin; M. Sarazin; D. Dormont; H. Hampel; H.Study Grp
2016
10.4088/JCP.15m10413
Reduced reticulum-mitochondria Ca2+ transfer is an early and reversible trigger of mitochondrial dysfunctions in diabetic cardiomyopathy
M. Dia; L. Gomez; H. Thibault; N. Tessier; C. Leon; C. Chouabe; S. Ducreux; N. Gallo-Bona; E. Tubbs; N. Bendridi; S. Chanon; A. Leray; L. Belmudes; Y. Coute; M. Kurdi; M. Ovize; J. Rieusset; M. Paillard
2020
10.1007/s00395-020-00835-7
Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure ADRIFT a Randomized Pilot Study
G. Duthoit; J. Silvain; E. Marijon; G. Ducrocq; A. Lepillier; C. Frere; S.F. Dimby; B. Popovic; N. Lellouche; I. Martin-Toutain; C. Spaulding; E. Brochet; D. Attias; J. Mansourati; L. Lorgis; D. Klug; N. Zannad; M. Hauguel-Moreau; N. Braik; S. Deltour; A. Ceccaldi; H. Wang; N. Hammoudi; D. Brugier; E. Vicaut; J.M. Juliard; G. Montalescot; A.D.R.I.F.T. Investigators
2020
10.1161/CIRCINTERVENTIONS.119.008481
Reduced sexual dichromatism, mutual ornamentation, and individual quality in the monogamous Zenaida dove Zenaida aurita
A. Quinard; F. Cezilly; S. Motreuil; J.M. Rossi; C. Biard
2017
10.1111/jav.00902
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
O. Sanchez; A. Charles-Nelson; W. Ageno; S. Barco; H. Binder; G. Chatellier; D. Duerschmied; K. Empen; M. Ferreira; P. Girard; ; D. Jimenez; S. Katsahian; M. Kozak; M. Lankeit; N. Meneveau; P. Pruszczyk; A. Petris; M. Righini; S. Rosenkranz; S. Schellong; B. Stefanovic; P. Verhamme; K. de Wit; E. Vicaut; A. Zirlik; ; G. Meyer; P.E.I.T.H.O.3 Investigators
Submitted
10.1055/a-1653-4699
Reduced-Intensity (FB2) Vs Reduced-Toxicity Myeloablative (FB3/FB4) Fludarabine/Busulfan Based Conditioning Regimens for Non-Hodgkin Lymphoma (NHL) Allografted Adult Patients: A Retrospective Study on Behalf of the Francophone Society of Bone Marrow Trans
A. Le Bourgeois; M. Labopin; D. Blaise; P. Ceballos; S. Vigouroux; R.Peffault de Latour; F. Suarez; E. Deconick; S. Chantepie; J.O. Bay; C.E. Bulabois; E. Daguindau; N. Contentin; I. Yakoub-Agha; J. Cornillon; S. Francois; P. Turlure; A. Charbonnier; P.S. Rohrlich; S. Nguyen; N. Maillard; T. Marchand; M. Mohty; P. Chevallier
2016
10.1182/blood.V128.22.980.980
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
J. Gauthier; L. Castagna; F. Garnier; T. Guillaume; G. Socie; S. Maury; N. Maillard; R. Tabrizi; T. Marchand; J. Malfuson; A. Gac; E. Gyan; M. Mercier; Y. Beguin; J. Delage; P. Turlure; A. Marcais; S. Nguyen; R. Dulery; J. Bay; A. huynh; E. Daguindau; J. Cornillon; C. Regny; M. Michallet; P. de latour; I. Yakoub-Agha; D. Blaise
2017
10.1038/bmt.2016.349
Reduced-Intensity Conditioning With Fludarabine and Busulfan Versus Fludarabine and Melphalan for Patients With Acute Myeloid Leukemia: A Report From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
F. Baron; M. Labopin; A. Peniket; P. Jindra; B. Afanasyev; M.A. Sanz; E. Deconinck; A. Nagler; M. Mohty
2015
10.1002/cncr.29163
Reduced-intensity versus reduced-toxicity myeloablative fludarabine/busulfan-based conditioning regimens for allografted non-Hodgkin lymphoma adult patients: a retrospective study on behalf of the Societe Francophone de Greffe de Moelle et de Therapie Cel
A. Le Bourgeois; M. Labopin; D. Blaise; P. Ceballos; S. Vigouroux; P. de latour; A. Marcais; C.E. Bulabois; J.O. Bay; S. Chantepie; E. Deconinck; E. Daguindau; N. Contentin; I. Yakoub-Agha; J. Cornillon; M. Mercier; P. Turlure; A. Charbonnier; P.S. Rorhlich; S. N'Guyen; N. Maillard; T. Marchand; M. Mohty; P. Chevallier; S.Francophon Moe
2017
10.1093/annonc/mdx274
Reducing Cybersickness by Geometry Deformation
R. Lou; J.R. Chardonnet
2019
Reducing Cybersickness by Geometry Deformation
R. Lou; J.R. Chardonnet
2019
Reducing diagnostic turnaround times of exome sequencing for families requiring timely diagnoses
A. Bourchany; C. Thauvin-Robinet; D. Lehalle; A.L. Bruel; A. Masurel-Paulet; N. Jean; S. Nambot; M. Willems; L. Lambert; S.El Chehadeh-Djebbar; E. Schaefer; A. Jaquette; J. St-Onge; T. Jouan; M. Chevarin; P. Callier; A.L. Mosca-Boidron; N. Laurent; M. Lefebvre; F. Huet; N. Houcinat; S. Moutton; C. Philippe; F. Tran-Mau-Them; A. Vitobello; P. Kuentz; Y. Duffourd; J.B. Riviere; J. Thevenon; L. Faivre
2017
10.1016/j.ejmg.2017.08.011
Reducing pesticide use through optimal reallocation at different spatial scales: The case of French arable farming
S. Kahindo; S. Blancard
Submitted
10.1111/agec.12703
Reducing pesticide use while preserving crop productivity and profitability on arable farms
M. Lechenet; F. Dessaint; G. Py; D. Makowski; N. Munier-Jolain
2017
10.1038/nplants.2017.8

Pages